DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Monday, 1 August 2016

THREO ERYTHRO ISOMERS EXAMPLES

 Figure

(5 R*,1′R*)-5-[3,5-Di-tert-butyl-4-hydroxyphenyl)hydroxymethyl]-2-ethyl-1,2-isothiazolidine-1,1-dioxide 12a (threo) and (5S*,1′R*)-5-[3,5-Di-tert-butyl-4-hydroxyphenyl)hydroxymethyl]-2-ethyl-1,2-isothiazolidine-1,1-dioxide 12b (erythro)








Compound 12a: mp 160−162 °C. 1H NMR (500 MHz, (CDCl3 δ) 1.25 (t, J = 7.3 Hz, 3H), 1.43 (s, 18H), 1.84 (m, 1H), 1.94 (m, 1H), 3.03 (ddd,J = 9.1, 8.2, 7.2 Hz, 1H), 3.08 (dq, J = 13.4, 7.2 Hz, 1H), 3.18 (ddd, J = 9.1, 8.0, 3.5 Hz, 1H), 3.23 (dq, J = 13.4, 7.2 Hz, 1H), 3.53 (m, 1H), 4.84 (d, J = 9.7 Hz 1H), 5.27 (s, 1H), 7.16 (s, 2H). 13C NMR (150 MHz, (CDCl3 δ) 13.18, 23.09, 30.24, 34.41, 39.42, 43.92, 63.67, 74.64, 123.58, 129.99, 136.38, 154.22. Elemental analysis: Calcd for C20H33O4NS: C; 62.63, H; 8.67, N; 3.65, S; 8.36, Found: C; 62.58, H; 8.62, N; 3.66, S; 8.32. Compound 12b: mp 78−96 °C. 1H NMR (500 MHz, (CDCl3 δ) 1.25 (t, J = 7.3 Hz, 3H), 1.44 (s, 18H), 2.08 (m, 1H), 2.60 (dq, J = 13.0, 8.5 Hz, 1H), 3.07 (m, 1H), 3.08 (m, 1H), 3.21 (dq, J = 13.3, 7.2 Hz, 1H), 3.28 (m, 1H), 3.31 (d, J = 2.6 Hz, 1H), 3.38 (td, J = 8.5, 2.1 Hz 1H), 5.21 (s, 1H), 5.40 (brs, 1H), 7.15 (s, 2H). 13C NMR (150 MHz, (CDCl3 δ) 13.18, 18.30, 30.28, 34.43, 39.46, 44.56, 63.21, 69.19, 122.41, 129.94, 136.14, 153.54. Elemental analysis: Calcd for C20H33O4NS: C; 62.63, H; 8.67, N; 3.65, S; 8.36, Found. C; 62.19, H; 8.63, N; 3.62, S; 8.10.


PAPER

Development of One-Pot Synthesis of New Antiarthritic Drug Candidate S-2474 with High E-Selectivity

Chemical Development Department, CMC Development Laboratories, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-chome, Amagasaki, Hyogo 660-0813, Japan, and Shionogi Research Laboratories, Shionogi & Co., Ltd., 12-4, Sagisu 5-chome, Fukushima-ku, Osaka 553-0002, Japan
Org. Process Res. Dev.200812 (3), pp 442–446
DOI: 10.1021/op800008w
 
* To whom correspondence should be addressed. Telephone: +81-6-6401-8198 . Fax: +81-6-6401-1371. E-mail:takemasa.hida@shionogi.co.jp., †
Chemical Development Department, CMC Development Laboratories.
, ‡Shionogi Research Laboratories.
Abstract Image
A one-pot synthesis of S-2474 was developed to overcome the problems of a large number of steps, low stereoselectivity, low yield, a large amount of waste, and severe reaction conditions. Aldol-type condensation of 3,5-di-tert-butyl-4-hydroxybenzaldehyde and N-ethyl-γ-sultam was carried out with LDA and then quenched with water. Dehydration proceeded under basic conditions, providing S-2474 directly as a single isomer on the benzylidene double bond. The reaction mechanism appears to involve a quinone methide intermediate. Environmental assessment of the development of this compound is also discussed in this paper.
?///////New,  Antiarthritic , Drug Candidate,  S-2474, Shionogi Research Laboratories, cyclooxygenase-2,  (COX-2),  5-lipoxygenase , (5-LO),

No comments:

Post a Comment